Form 4: ICU Medical Director Elisha Finney Equity Transaction

Director Elisha W. Finney acquired 1,254 shares of ICU Medical common stock via restricted stock unit vesting and was granted 1,475 new units.

Summary

• Director Elisha W. Finney exercised and vested 1,254 restricted stock units (RSUs) on May 13, 2026.
• Following the transaction, the director holds 5,249 shares of common stock directly.
• A new grant of 1,475 restricted stock units was awarded to the director on the same date.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral administrative filing regarding director compensation.

Positives

• Director maintains a direct equity stake of 5,249 shares, aligning interests with shareholders.

Negatives

• None identified.

Risks

• None identified.

Future Outlook

The newly granted 1,475 restricted stock units are scheduled to vest on May 13, 2027.

Industry Context

StockSavvy.ai notes that routine equity compensation filings for directors are standard corporate governance practices and do not typically signal shifts in company strategy or financial performance.

Comparison to Industry Standards

• The equity compensation structure is consistent with standard practices for non-employee directors in the medical device sector.

Stakeholder Impact

• Minimal impact on shareholders as this represents standard director compensation.

Next Steps

• Vesting of 1,475 restricted stock units on May 13, 2027.

Key Dates

Keywords

ICU Medical, ICUI, Form 4, Insider Trading, Restricted Stock Units, Director Ownership